Hemidesmosomal variants of epidermolysis bullosa: Mutations in the α6β4 integrin and the 180-kD bullous pemphigoid antigen/type XVII collagen genes

Experimental Dermatology

Volumn 7, Issue 2-3, 1998, Pages 46-64

  Pulkkinen, L ^b   Uitto, J ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

^b NONE

Author keywords

Cutaneous basement membrane zone; Epidermolysis bullosa; Heritable skin diseases

Indexed keywords

INTEGRIN;

DISEASE CLASSIFICATION; DISEASE SEVERITY; EPIDERMOLYSIS BULLOSA; GENE MUTATION; HEMIDESMOSOME; HUMAN; MUSCULAR DYSTROPHY; PEMPHIGOID; PHENOTYPE; REVIEW;

EID: 0031893142     PISSN: 09066705     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0625.1998.tb00304.x     Document Type: Review

References (121)

1. Gedde-Dahl T Jr. Epidermolysis bullosa: A clinical, genetic and epidemiological study. Baltimore: Johns Hopkins Press, 1971.
2. Fine J-D, Bauer E A, Briggaman R A et al. Revised clinical and laboratory criteria for subtypes of epidermolysis bullosa. A consensus report by the Subcommittee on Diagnosis and Classification of the National Epidermolysis Bullosa Registry. J Am Acad Dermatol 1991: 24: 119-135.
3. Uitto J, Christiano A M. Molecular genetics of the cutaneous basement membrane zone. Perspectives on epidermolysis bullosa and other blistering skin diseases. J Clin Invest 1992: 90: 687-692.
4. Smith L T. Ultrastructural findings in epidermolysis bullosa. Arch Dermatol 1993: 129: 1578-1584.
5. Eady R A, McGrath J A, McMillan J R. Ultrastructural clues to genetic disorders of skin: the dermal-epidermal junction. J Invest Dermatol 1994: 103: 13S-18S.
6. Christiano A M, Uitto J. Molecular complexity of the cutaneous basement membrane zone. Revelations from the paradigms of epidermolysis bullosa. Exp Dermatol 1996: 5: 1-11.
7. Corden L D, McLean W H I. Human keratin diseases: hereditary fragility of specific epithelial tissues. Exp Dermatol 1996: 5: 297-307.
8. Uitto J, Pulkkinen L, McLean W H I. Epidermolysis bullosa: a spectrum of clinical phenotypes explained by molecular heterogeneity. Molec Med Today 1997: 3: 457-465.
9. Pulkkinen L, Uitto J, Christiano A M. The molecular basis of the junctional forms of epidermolysis bullosa. In: epidermolysis bullosa: clinical, epidemiologic and laboratory advances, and the findings of the National Epidermolysis Bullosa Registry (Fine J-D, Bauer A, McGuire J, Moshell A, eds). Baltimore, MD: The Johns Hopkins University Press: (In Press).
10. Uitto J, Pulkkinen L, Christiano A M. The molecular basis of the dystrophic forms of epidermolysis bullosa. In: epidermolysis bullosa: clinical, epidemiologic and laboratory advances, and the findings of the National Epidermolysis Bullosa Registry (Fine J-D, Bauer E A, McGuire J, Moshell A, eds). Baltimore, MD: The Johns Hopkins University Press: (In Press).
11. 3 chain of laminin 5 (LAMB3). Hum Mutat 1995: 6: 77-84.
12. Christiano A M, Hoffman G G, Zhang X et al. A strategy for identification of sequence variants in COL7A1 and a novel 2-bp deletion mutation in recessive dystrophic epidermolysis bullosa. Hum Mutat 1997: 10: 408-414.
13. Hovnanian A, Pollack E, Hilal L, Rochat A et al. A missense mutation in the rod domain of keratin 14 associated with recessive epidermolysis bullosa simplex. Nat Genet 1993: 3: 327-332.
14. Rugg E L, McLean W H I, Lane E B et al. A functional "knock-out" for human keratin 14. Genes Dev 1994: 8: 2563-2573.
15. Chan Y, Anton-Lamprecht I, Yu Q C et al. A human keratin 14 "knock-out: the absence of K14 leads to severe epidermolysis bullosa simplex and a function for an intermediate filament protein. Genes Dev 1994: 8: 2574-2587.
16. Cui Y, Hagan K W, Zhang S, Peltz S W. Identification and characterization of genes that are required for the accelerated degradation of mRNAs containing a premature translational termination codon. Genes Dev 1995: 9: 423-436.
17. Vailly J, Pulkkinen L, Christiano A M et al. Identification of a homozygous exon skipping mutation in the LAMC2 gene in patient with Herlitz junctional epidermolysis bullosa. J Invest Dermatol 1995: 104: 434-437.
18. 3 chain gene of laminin 5 (LAMB3) in Herlitz junctional epidermolysis bullosa. Genomics 1994: 24: 357-360.
19. 3 chain gene of laminin 5 (LAMA3) in lethal (Herlitz) junctional epidermolysis bullosa. Hum Mol Genet 1995: 4: 959-962.
20. Christiano A M, Pulkkinen L, McGrath J A, Uitto J. Mutation-based prenatal diagnosis of Herlitz junctional epidermolysis bullosa. Prenatal Diag 1997: 17: 343-354.
21. 3 chain (LAMB3) in generalized atrophic benign epidermolysis bullosa, a recessively inherited blistering skin disease. J Invest Dermatol 1995: 104: 467-474.
22. McGrath J, Christiano A M, Pulkkinen L, Eady R A J, Uitto J. Compound heterozygosity for nonsense and missense mutations in the LAMB3 gene in nonlethal junctional epidermolysis bullosa. J Invest Dermatol 1996: 106: 775-777.
23. Tidman M J, Eady R A J. Evaluation of anchoring fibrils and other components of the dermal-epidermal junction in dystrophic epidermolysis bullosa by quantitative ultrastructural technique. J Invest Dermatol 1985: 84: 374-377.
24. Järvikallio A, Pulkkinen L, Uitto J. Molecular basis of dystrophic epidermolysis bullosa: mutations in the type VII collagen gene (COL7A1). Hum Mutat 1997: 10: 338-347.
25. Christiano A M, Uitto J. Molecular diagnosis of inherited skin diseases: The paradigm of dystrophic epidermolysis bullosa. Adv Dermatol 1996: 11: 199-214.
26. Green K J, Jones J C R. Desmosomes and hemidesmosomes: structure and function of molecular components. FASEB J 1996: 10: 871-881.
27. Borradori L, Sonnenberg A. Hemidesmosomes: roles in adhesion, signaling and human diseases. Curr Op Cell Biol 1996: 8: 647-656.
28. Burgeson R E. Type VII collagen, anchoring fibrils, and epidermolysis bullosa. J Invest Dermatol 1993: 101: 252-255.
29. Keene D R, Sakai L Y, Lunstrum G P, Morris N P, Burgeson R E. Type VII collagen forms an extended network of anchoring fibrils. J Cell Biol 1987: 104: 611-621.
30. Shimizu H, Ishiko A, Masunaga T et al. Most anchoring fibrils in human skin originate and terminate in the lamina densa. Lab Invest 1997: 76: 753-763.
31. Ruhrberg C, Watt F. The plakin family: versatile organizers of cytoskeletal architecture. Curr Opin Genet Dev 1997: 7: 392-397.
32. Skalli O, Jones J C R, Gagescu R, Goldman R D. IFAP-300 is common to desmosomes and hemidesmosomes and is a possible linker of intermediate filaments to these junctions. J Cell Biol 1994: 125: 159-170.
33. Kurpakus M A, Jones J C R. A novel hemidesmosomal plaque component: tissue distribution and incorporation into assembling hemidesmosomes in an in vitro model. Exp Cell Res 1991: 194: 139-146.
34. 1 in epithelial basement membranes. Cell 1991: 65: 599-610.
35. 1 integrin is required for normal development of the epidermal basement membrane. J Cell Biol 1997: 137: 729-742.
36. Burgeson R E, Chiquet N, Deutzmann R et al. A new nomenclature for laminins. Matrix Biol 1994: 14: 209-211.
37. Aumailley M, Krieg T. Laminins: A family of diverse multifunctional molecules of basement membranes. J Invest Dermatol 1996: 106: 209-214.
38. Masunaga T, Shimizu H, Ishiko A et al. Localization of laminin-5 in the epidermal basement membrane. J Histochem Cytochem 1996: 44: 1223-1230.
39. Champliaud M F, Lunstrum G P, Rousselle P, Nishiyama T, Keene D R, Burgeson R E. Human amnion contains a novel laminin variant, laminin 7, which like laminin 6, covalently associates with laminin 5 to promote stable epithelial-stromal attachment. J Cell Biol 1996: 132: 1189-1198.
40. Martin G R, Timpl R. Laminin and other basement membrane components. Annu Rev Cell Biol 1987: 3: 57-85.
41. 3 isoform. J Cell Biol 1997: 137: 685-701.
42. Woods A, Couchman J R. Signaling from the matrix to the cytoskeleton: role of cell surface proteoglycans in matrix assembly. J Invest Dermatol 1996: 106: 531-537.
43. Miosge N, Gotz W, Sasaki T, Chu M L, Timpl R, Herken R. The extracellular matrix proteins fibulin-1 and fibulin-2 in the early human embryo. Histochem J 1996: 28: 109-116.
44. Zillikens D, Kawahara Y, Ishiko A et al. A novel subepidermal blistering disease with autoantibodies to a 200-kDa antigen of the basement membrane zone. J Invest Dermatol 1996: 106: 1333-1338.
45. 2 chain of laminin-5. J Invest Dermatol 1995: 105: 75-79.
46. Fine J D. 19-DEJ-1, a monoclonal antibody to the hemidesmosome-anchoring filament complex, is the only reliable immunohistochemical probe for all major forms of junctional epidermolysis bullosa. Arch Dermatol 1990: 126: 1187-1190.
47. Gayraud B, Hopfner B, Jassim A, Aumailley M, Bruckner-Tuderman L. Characterization of a 50 kDa component of epithelial basement membranes using GDA-J/F3 monoclonal antibody. J Biol Chem 1997: 272: 9531-9538.
48. Wiche G, Herrmann H, Leichtfried F, Pytela T. Plectin - a high-molecular-weight cytoskeletal polypeptide component that copurifies with intermediate filaments of the vimentin type. Cold Spring Harb Symp Quant Biol 1981: 46: 475-482.
49. Wiche G. Plectin: general overview and appraisal of its potential role as a subunit of the cytomatrix. CRC Crit Rev Biochem 1989: 24: 41-67.
50. Wiche G, Krepler R, Artlieb U, Pytela R, Denk H. Occurrence and immunolocalization of plectin in tissues. J Cell Biol 1983: 97: 887-901.
51. Liu C G, Maercker C, Castanon M J, Hauptmann R, Wiche G. Human plectin - organization of the gene, sequence-analysis, and chromosome localization (8q24). Proc Natl Acad Sci 1996: 93: 4278-4283.
52. McLean W H I, Pulkkinen L, Smith F J D et al. Loss of plectin causes epidermolysis bullosa with muscular dystrophy: cDNA cloning and genomic organization. Genes Dev 1996: 10: 1724-1735.
53. Ruhrberg C, Nasser Hajibagheri M A, Simon M, Dooley T P, Watt F M. Envoplakin, a novel precursor of the cornified envelope that has homology to desmoplakin. J Cell Biol 1996: 134: 715-729.
54. Ruhrberg C, Nasser Hajibagheri M A, Parry D A D, Watt F M. Periplakin, a novel component of cornified envelopes and desmosomes that belongs to the plakin family and forms complexes with envoplakin. J Cell Biol 1997: 139: 1835-1849.
55. Aho S, McLean W H I, Li K, Uitto J. cDNA cloning, mRNA expression, and chromosomal mapping of human and mouse periplakin genes. Genomics 1998: 48: 242-247.
56. Elliott C E, Becker B, Oehler S, Castanon M J, Haputmann R, Wiche G. Plectin transcript diversity: identification and tissue distribution of variants with distinct first coding exons and rodless isoforms. Genomics 1997: 42: 115-125.
57. Hieda Y, Nishizawa Y, Uematsu J, Owaribe K. Identification of a new hemidesmosomal protein, HD1: a major high molecular mass component of isolated hemidesmosomes. J Cell Biol 1992: 116: 1497-1506.
58. Uitto J, Pulkkinen L, Smith F J D, McLean W H I. Plectin and human genetic disorders of the skin and muscle. The paradigm of epidermolysis bullosa with muscular dystrophy. Exp Dermatol 1996: 5: 237-246.
59. Stanley J R, Hawley-Nelson P, Yuspa S H, Shevach E M, Katz S I. Characterization of bullous pemphigoid antigen: a unique basement membrane protein of stratified squamous epithelia. Cell 1981: 24: 897-903.
60. Liu Z, Diaz L A, Troy J L et al. A passive transfer model of the organ-specific autoimmune disease, bullous pemphigoid, using antibodies generated against the hemidesmosomal antigen, BP180. J Clin Invest 1993: 92: 2480-2488.
61. Guo L, Degenstein L, Dowling J et al. Gene targeting of BPAG1: abnormalities in mechanical strength and cell migration in stratified epithelia and neurologic degeneration. Cell 1995: 81: 233-244.
62. Brown A, Bernier G, Mathier M, Rossant J, Kothary R. The mouse dystonia musculorum gene is a neural isoform of bullous pemphigoid antigen 1. Nat Genet 1995: 10: 301.
63. Brown A, Dalpe G, Mathieu M, Kothary R. Cloning and characterization of the neural isoforms of human dystonin. Genomics 1995: 29: 777-780.
64. Morrison L H, Labib R S, Zone J J, Diaz L A, Anhalt G J. Herpes gestationis autoantibodies recognize a 180 kD human epidermal antigen. J Clin Invest 1988: 31: 2023-2036.
65. Giudice G, Emery D J, Diaz L A. Cloning and primary structural analysis of the bullous pemphigoid autoantigen BP180. J Invest Dermatol 1992: 99: 243-250.
66. Li K, Tamai K, Tan E M L, Uitto J. Cloning of type XVII collagen. Complementary and genomic DNA sequences of mouse 180-kDa bullous pemphigoid antigen (BPAG2) predict an interrupted collagenous domain, a transmembrane segment, and unusual features in the 5′-end of the gene and the 3′-untranslated region of the mRNA. J Biol Chem 1993: 268: 8825-8834.
67. Masunaga T, Shimizu H, Yee C et al. The extracellular domain of BPAG2 localizes to anchoring filaments and its carboxyl terminus extends to the lamina densa of normal human epidermal basement membrane. J Invest Dermatol 1997: 109: 200-206.
68. Marinkovich M P, Taylor T B, Keene D R, Burgeson R E, Zone J J. LAD-1, the linear IgA bullous dermatosis autoantigen, is a novel 120-kDa anchoring filament protein synthesized by epidermal cells. J Invest Dermatol 1996: 106: 734-738.
69. Zone J J, Taylor T B, Meyer L J, Peterson M J. The 97-kDa linear IgA bullous disease antigen is identical to a portion of the extracellular domain of the 180-kDa bullous pemphigoid antigen, BPAG2. J Invest Dermatol 1998: 110: 207-210.
70. Megahed M, Motoki K, McGrath J, LaForgia S, Uitto J. Cloning of the human linear IgA disease gene (LADA) encoding a novel anchoring filament protein, ladinin. J Invest Dermatol 1996: 106: 832 (abstract).
71. Motoki K, Megahed M, LaForgia S, Uitto J. Cloning and chromosomal mapping of mouse ladinin, a novel basement membrane zone component. Genomics 1997: 39: 323-330.
72. Ruoslahti E, Pierschbacher M D. New perspectives in cell adhesion: RGD and integrins. Science 1987: 238: 491-497.
73. Hynes R O. Integrins: versatility, modulation, and signaling in cell adhesion. Cell 1992: 69: 11-25.
74. 4 integrin heterodimer is a component of hemidesmosomes. Proc Natl Acad Sci USA 1990: 87: 8970-8974.
75. Sonnenberg A, Calafat J, Janssen H et al. Integrin alpha 6/beta 4 complex is located in hemidesmosomes, suggesting a major role in epidermal cell-basement membrane adhesion. J Cell Biol 1991: 113: 907-917.
76. 4 integrin gene (ITGB4): A homozygous splice-site mutation in a patient with junctional epidermolysis bullosa associated with pyloric atresia. Lab Invest 1997: 76: 823-833.
77. 6 integrin mutation in junctional epidermolysis bullosa with congenital duodenal atresia. Hum Mol Genet 1997: 6: 669-674.
78. 1 suggest different roles in mouse development. Dev Dyn 1995: 204: 240-258.
79. Hogervorst F, Kuikman I, von dem Borne A E G Jr, Sonnenberg A. Cloning and sequence analysis of beta-4 cDNA: an integrin subunit that contains a unique 118 kD cytoplasmic domain. EMBO J 1990: 9: 765-770.
80. 4. J Cell Biol 1990: 111: 1593-1604.
81. 4E is produced by partial retention of intronic sequences. Biochem Biophys Res Commun 1997: 235: 826-830.
82. 6 integrin variants. Cell Adhes Commun 1995: 3: 143-161.
83. Andra K, Lassmann H, Bittner R et al. Targeted inactivation of plectin reveals essential function in maintaining the integrity of skin, muscle, and heart cytoarchitecture. Genes Dev 1997: 11: 3143-3156.
84. Nikolic B, MacNulty E, Mir B, Wiche G. Basic amino acid residue cluster within nuclear targeting sequence motif is essential for cytoplasmic plectin-vimentin network junctions. J Cell Biol 1996: 134: 1455-1467.
85. Foisner R, Malecz N, Dressel N, Stadler C, Wiche G. M-phase-specific phosphorylation and structural rearrangement of the cytoplasmic cross-linking protein plectin involve p34(cdc2) kinase. Mol Biol Cell 1996: 7: 273-288.
86. 4 subunit. J Cell Sci 1997: 110: 169-178.
87. 4 forms a complex with the cytoskeletal protein HD1 and induces its redistribution in transfected COS-7 cells. Mol Biol Cell 1997: 8: 555-566.
88. 4 subunit that is critical to its localization in hemidesmosomes regulates the distribution of HD1/plectin in COS-7 cells. J Cell Sci 1997: 110: 1705-1716.
89. 4 integrin, hemidesmosomal components of basal keratinocytes. Biochem Biophys Res Commun 1998: 243: 694-699.
90. 4 integrin subunit. J Cell Biol 1997: 136: 1333-1347.
91. 6 integrin. J Cell Biol 1995: 130: 117-125.
92. 4 null mice. Nat Genet 1996: 13: 366-369.
93. 6 integrin in pyloric atresia-junctional epidermolysis bullosa syndrome. Arch Dermatol 1996: 132: 919-925.
94. 4 integrin gene (ITGB4). Am J Pathol 1997: 152: 157-166.
95. Rousselle P, Keene D R, Ruggiero F, Champliaud M-F, van der Rest M, Burgeson R E. Laminin 5 binds the NC-1 domain of type VII collagen. J Cell Biol 1997: 138: 719-728.
96. Hashimoto I, Schnyder U W, Anton-Lamprecht I. Epidermolysis bullosa hereditaria with junctional blistering in an adult. Dermatologica 1976: 152: 72-86.
97. Hintner H, Wolff K. Generalized atrophic benign epidermolysis bullosa. Arch Dermatol 1982: 118: 375-384.
98. Jonkman M F, de Jong M C, Heeres K et al. 180-kD bullous pemphigoid antigen (BP180) is deficient in generalized atrophic benign epidermolysis bullosa. J Clin Invest 1995: 95: 1345-1352.
99. Pohla-Gubo G, Lazarova Z, Giudice G J et al. Diminished expression of the extracellular domain of bullous pemphigoid antigen 2 (BPAG2) in the epidermal basement membrane of patients with generalized atrophic benign epidermolysis bullosa. Exp Dermatol 1995: 24: 357-360.
100. Gatalica B, Pulkkinen L, Li K et al. Cloning of the human type XVII collagen gene (COL17A1) and detection of novel mutations in generalized atrophic benign epidermolysis bullosa. Am J Hum Genet 1997: 60: 352-365.
101. Schumann H, Hammami-Hauasli N, Pulkkinen L et al. Three novel homozygous point mutations and a new polymorphism in the COL17A1 gene: Relation to biological and clinical phenotypes of junctional epidermolysis bullosa. Am J Hum Genet 1997: 60: 1344-1353.
102. McGrath JA, Gatalica B, Li K et al. Compound heterozygosity for a dominant glycine substitition and a recessive internal duplication mutation in the type XVII collagen gene results in junctional epidermolysis bullosa and abnormal dentition. Am J Pathol 1996: 148: 1787-1796.
103. Jonkman M F, Scheffer H, Stulp R et al. Revertant mosaicism in epidermolysis bullosa caused by gene mitotic conversion. Cell 1997: 88: 543-551.
104. 4 that inhibit hemidesmosome formation. J Invest Dermatol 1994: 103: 31S-38S.
105. 4 subunit are associated with junctional epidermolysis bullosa with pyloric atresia. Nat Genet 1995: 10: 229-234.
106. 4 integrin gene (ITGB4) underlies mild, non-lethal phenotype of epidermolysis bullosa with pyloric atresia. Am J Pathol 1998: 152: (In Press).
107. 6 gene in junctional epidermolysis bullosa with pyloric atresia. J Clin Invest 1997: 99: 2826-2831.
108. Yerlinsky Y, Kuliev A M. Preimplantation diagnosis of genetic diseases: a new technique in assisted reproduction. New York, NY: Wiley-Liss, 1993: pp. 1-144.
109. Khavari P A, Krueger G G. Cutaneous gene therapy. Dermatol Clin 1997: 15: 27-35.
110. McGrath J A, Gatalica B, Christiano A M. Mutations in the gene encoding the 180-kD bullous pemphigoid antigen (BPAG2), a hemidesmosomal transmembrane collagen (type XVII), in generalized atrophic benign epidermolysis bullosa. Nat Genet 1995: 11: 83-86.
111. McGrath J A, Darling T, Gatalica B et al. A homozygous deletion mutation in the gene encoding the 180-kD bullous pemphigoid antigen (BPAG2) in a family with generalized atrophic benign epidermolysis bullosa. J Invest Dermatol 1996: 106: 771-774.
112. Darling T N, McGrath J A, Yee C et al. Premature termination codons are present on both alleles of the bullous pemphigoid antigen 2/Type XVII collagen gene in five Austrian families with generalized atrophic benign epidermolysis bullosa. J Invest Dermatol 1997: 108: 463-468.
113. Chavanas S, Gache Y, Tadini G L et al. A homozygous in-frame deletion in the collagenous domain of bullous pemphigoid antigen BP180 (type XVII collagen) causes generalized atrophic benign epidermolysis bullosa. J Invest Dermatol 1997: 109: 74-78.
114. Shimizu H, Takizawa Y, Pulkkinen L et al. The 97-kD linear IgA bullous dermatosis antigen is not expressed in a patient with generalized atrophic benign epidermolysis bullosa with a novel homozygous G252X mutation in COL17A1. Submitted.
115. Mellerio J E, Denyer J E, Atherton D J, Eady R A J, McGrath J A. Prognostic implications of determining 180 kDa bullous pemphigoid antigen (BPAG2) gene/protein pathology in neonatal junctional epidermolysis bullosa. Br J Dermatol 1998: 138: In Press.
116. 4 Integrin. J Invest Dermatol 1997: 108: 943-946.
117. Smith F J D, Eady R A J, Leigh I M et al. Plectin deficiency results in muscular dystrophy with epidermolysis bullosa. Nat Genet 1996: 13: 450-457.
118. Pulkkinen L, Smith F J D, Shimizu H et al. Homozygous deletion mutations in the plectin gene (PLEC1) in patients with epidermolysis bullosa simplex associated with late-onset muscular dystrophy. Hum Mol Genet 1996: 5: 1539-1546.
119. Chavanas S, Pulkkinen L, Gache Y et al. A homozygous mutation in the PLEC1 gene in patients with epidermolysis bullosa simplex with muscular dystrophy. J Clin Invest 1996: 98: 2196-2200.
120. Mellerio J E, Smith F J D, McMillan J R et al. Recessive epidermolysis bullosa simplex associated with plectin mutations: infantile respiratory complications in two unrelated cases. Br J Dermatol 1997: 137: 898-906.
121. Dang M, Pulkkinen L, Smith F J D, McLean W H I, Uitto J. Novel compound heterozygous mutations in the plectin gene in epidermolysis bullosa with muscular cystrophy (EB-MD), and use of protein truncation test for detection of premature termination codon mutations. Lab Invest 1998: 78: 195-204.